Filing Details

Accession Number:
0001209191-14-059297
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-23 16:18:15
Reporting Period:
2014-09-19
Filing Date:
2014-09-23
Accepted Time:
2014-09-23 16:18:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550395 David Altshuler C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Transaction Summary
Sold: 5,000 shares Avg. Price: $102.25 Total Value: $511,250.00
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-19 5,000 $59.55 5,000 No 4 M Direct
Common Stock Disposition 2014-09-19 2,500 $99.75 2,500 No 4 S Direct
Common Stock Disposition 2014-09-19 2,500 $104.75 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-09-19 5,000 $0.00 5,000 $59.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,500 2022-05-31 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
  2. Fully vested.